Telix Pharmaceuticals

ISIN AU000000TLX2

 | 

WKN A2H7JK

Market cap (in EUR)
2,634 m
Country
Australia
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.
Show more Show less
Healthcare Healthcare Equipment Other Medical Devices Australia

Financials

Key metrics

Market capitalisation, EUR 2,634 m
EPS, EUR -
P/B ratio 7.2
P/E ratio 275.1
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 478 m
Net income, EUR 30 m
Profit margin 6.37%

What ETF is Telix Pharmaceuticals in?

There are 8 ETFs which contain Telix Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Telix Pharmaceuticals is the Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing.
ETF Weight Investment focus Fund size (in m EUR)
Vanguard FTSE Developed World UCITS ETF Distributing 0.00%
Equity
World
3,524
Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing 0.07%
Equity
Asia Pacific
1,276
Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Distributing 0.04%
Equity
Asia Pacific
Social/Environmental
25
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
488
Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF (USD) Accumulating 0.07%
Equity
Asia Pacific
405
Vanguard FTSE Developed World UCITS ETF Acc 0.00%
Equity
World
4,746
Vanguard FTSE All-World UCITS ETF (USD) Accumulating 0.00%
Equity
World
26,195
Vanguard FTSE All-World UCITS ETF (USD) Distributing 0.00%
Equity
World
18,763
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.